Related Experiment Video
Updated: Feb 19, 2026
05:46
Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
Published on: December 2, 2022
2.2K
Genetic prognostication in uveal melanoma
Mehmet Dogrusöz1, Martine J Jager1
1Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands.
Acta Ophthalmologica
|November 7, 2017
Summary
Genetic markers in uveal melanoma (UM) significantly improve patient prognostication. Key genetic factors like chromosome 3, 8q, 6p aberrations, and gene mutations aid in predicting metastatic risk for better patient care.
Area of Science:
- Ophthalmology
- Oncology
- Genetics
Background:
- Uveal melanoma (UM) is a rare eye cancer with a high risk of metastasis.
- Accurate prognostication is crucial for patient management, follow-up, and clinical trial stratification.
- Conventional clinicopathologic features have limitations in predicting UM outcomes.
Purpose of the Study:
- To review and synthesize current knowledge on genetic prognostic indicators in uveal melanoma.
- To compare available genetic testing methods for UM prognostication.
- To discuss the clinical application and future directions of genetic prognostication in UM.
Main Methods:
- Review of scientific literature on genetic alterations and prognostic markers in uveal melanoma.
- Analysis of chromosome aberrations (e.g., monosomy 3, gain of 8q, gain of 6p).
- Examination of gene mutations (e.g., BAP1, SF3B1, EIF1AX) associated with patient outcomes.
Main Results:
- Specific chromosomal abnormalities, including monosomy 3 and gain of 8q, are strongly linked to increased metastatic risk in UM.
- Gain of chromosome 6p is associated with a lower risk of metastasis.
- Mutations in genes like BAP1, SF3B1, and EIF1AX correlate with patient prognosis.
Conclusions:
- Genetics plays a pivotal role in understanding UM pathogenesis and refining prognostication.
- Advances in genetic testing offer improved methods for classifying UM risk.
- Further research is needed to address the reliability of prognostic genetic tests and optimize their clinical use.
Related Concept Videos
02:07Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
01:20The Retinoblastoma Gene
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K